MedTrace Logo

Efficacy of Lactobacillus Reuteri Protectis on Functional Abdominal Pain (FAP) in Children 8-14 Years Old

NCT01498666 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2021-06-02

No results posted yet for this study

Summary

The present clinical trial will examine the use of L. reuteri Protectis in children with functional abdominal pain. The aim of the study is to evaluate the use of L. reuteri Protectis on pain (severity and frequency) in children of 8-14 years old and with diagnosis of functional abdominal pain (FAP).

Conditions

Interventions

DIETARY_SUPPLEMENT

L. reuteri protectis

1 tablet once daily for 4 weeks

DIETARY_SUPPLEMENT

Placebo tablet

1 tablet once daily for 4 weeks

Sponsors & Collaborators

  • Sprim CRO, Italia

    collaborator UNKNOWN

  • BioGaia AB

    lead INDUSTRY

Principal Investigators

  • Costantino DeGiacomo, MD · Niguarda Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
8 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01498666 on ClinicalTrials.gov